ATLANTIC SAPPHIRE ASA(OSL:ASA) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ASA. ASA was compared to 57 industry peers in the Food Products industry. The financial health of ASA is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ASA is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

ASA had negative earnings in the past year.

ASA had a negative operating cash flow in the past year.

ASA had negative earnings in each of the past 5 years.

ASA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -41.83%, ASA is not doing good in the industry: 92.98% of the companies in the same industry are doing better.

The Return On Equity of ASA (-51.90%) is worse than 89.47% of its industry peers.

		Industry Rank	Sector Rank
ROA	-41.83%
ROE	-51.9%
ROIC	N/A

ROA(3y)-33.29%

ROA(5y)-24.45%

ROE(3y)-41.53%

ROE(5y)-30.5%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ASA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ASA does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ASA has less shares outstanding

The number of shares outstanding for ASA has been reduced compared to 5 years ago.

ASA has a better debt/assets ratio than last year.

2.2 Solvency

ASA has an Altman-Z score of -2.63. This is a bad value and indicates that ASA is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of ASA (-2.63) is worse than 91.23% of its industry peers.

A Debt/Equity ratio of 0.15 indicates that ASA is not too dependend on debt financing.

The Debt to Equity ratio of ASA (0.15) is better than 89.47% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Altman-Z	-2.63

ROIC/WACCN/A

WACC8.25%

2.3 Liquidity

ASA has a Current Ratio of 1.41. This is a normal value and indicates that ASA is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.41, ASA is in line with its industry, outperforming 54.39% of the companies in the same industry.

A Quick Ratio of 1.16 indicates that ASA should not have too much problems paying its short term obligations.

ASA has a Quick ratio of 1.16. This is in the better half of the industry: ASA outperforms 70.18% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.41
Quick Ratio	1.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ASA have decreased strongly by -15536.76% in the last year.

ASA shows a decrease in Revenue. In the last year, the revenue decreased by -1.16%.

Measured over the past years, ASA shows a very strong growth in Revenue. The Revenue has been growing by 96.31% on average per year.

EPS 1Y (TTM)-15536.76%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-9167.75%

Revenue 1Y (TTM)-1.16%

Revenue growth 3Y30.69%

Revenue growth 5Y96.31%

Sales Q2Q%38.94%

3.2 Future

Based on estimates for the next years, ASA will show a very strong growth in Earnings Per Share. The EPS will grow by 89.14% on average per year.

Based on estimates for the next years, ASA will show a very strong growth in Revenue. The Revenue will grow by 22.71% on average per year.

EPS Next Y-270.21%

EPS Next 2Y61.36%

EPS Next 3Y89.14%

EPS Next 5YN/A

Revenue Next Year102.89%

Revenue Next 2Y86.18%

Revenue Next 3Y77.56%

Revenue Next 5Y22.71%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASA. In the last year negative earnings were reported.

The Price/Forward Earnings ratio is 0.22, which indicates a rather cheap valuation of ASA.

Based on the Price/Forward Earnings ratio, ASA is valued cheaper than 100.00% of the companies in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 20.74. ASA is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	0.22

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ASA's earnings are expected to grow with 89.14% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y61.36%

EPS Next 3Y89.14%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ASA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ATLANTIC SAPPHIRE ASA

OSL:ASA (5/5/2025, 7:00:00 PM)

6.6

-0.2 (-2.93%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)04-23 2025-04-23/amc

Earnings (Next)08-21 2025-08-21

Inst Owners1.23%

Inst Owner ChangeN/A

Ins Owners0.02%

Ins Owner ChangeN/A

Market Cap236.61M

Analysts40

Price Target627.82 (9412.42%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-14.69%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)51.35%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	0.22
P/S	1.33
P/FCF	N/A
P/OCF	N/A
P/B	0.09
P/tB	0.09
EV/EBITDA	N/A

EPS(TTM)-682.54

EYN/A

EPS(NY)30.57

Fwd EY463.25%

FCF(TTM)-27.04

FCFYN/A

OCF(TTM)-23.55

OCFYN/A

SpS4.97

BVpS76.74

TBVpS76.74

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-41.83%
ROE	-51.9%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-33.29%

ROA(5y)-24.45%

ROE(3y)-41.53%

ROE(5y)-30.5%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.05

Health

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	82.96%
Cap/Sales	70.39%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.41
Quick Ratio	1.16
Altman-Z	-2.63

F-Score3

WACC8.25%

ROIC/WACCN/A

Cap/Depr(3y)308.07%

Cap/Depr(5y)1123.22%

Cap/Sales(3y)260.86%

Cap/Sales(5y)664.03%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-15536.76%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-9167.75%

EPS Next Y-270.21%

EPS Next 2Y61.36%

EPS Next 3Y89.14%

EPS Next 5YN/A

Revenue 1Y (TTM)-1.16%

Revenue growth 3Y30.69%

Revenue growth 5Y96.31%

Sales Q2Q%38.94%

Revenue Next Year102.89%

Revenue Next 2Y86.18%

Revenue Next 3Y77.56%

Revenue Next 5Y22.71%

EBIT growth 1Y-2.65%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year75.66%

EBIT Next 3Y57.27%

EBIT Next 5Y25.94%

FCF growth 1Y14.83%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-104.37%

OCF growth 3YN/A

OCF growth 5YN/A

ATLANTIC SAPPHIRE ASA (ASA.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens